Navigation Links
The Wallick Companies Establish Sanford Goldston Memorial Fund
Date:3/4/2008

ize in affordable multifamily housing in the Midwest and other select regions of the U.S. Through its various operations, Wallick has developed and constructed hundreds of apartment complexes and currently manages more than 8,000 residential units in more than 80 properties. Founded in 1966 by Jack Wallick and Sandy Goldston and currently owned by Jack's children, Howard Wallick and Julie Wallick, the family businesses adhere to their founders' ideals of integrity and consistent quality. Additional information is available at http://www.wallickcos.com.

CONTACT:

Robin Yocum

614.212.2344

614.378.3286 cell


'/>"/>
SOURCE The Wallick Companies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
2. eWorld Companies, Inc. Establishes Strategic Alliance With Hemophilia Foundation of Southern California
3. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
4. Fortune 100 Companies Share Customer Experience Insights in Phoenix, Ariz., Feb. 25-27
5. URAC Announces Four More Companies in Process to Earn New Pharmacy Quality Management Accreditations
6. Legal Employer Provides Companies with Competitive Edge by Assuring Consumers that Workers are Legally Documented
7. Board Members of Five Massachusetts Companies Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
8. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
9. The Beryl Companies Hires Nancy Lecroy as Vice President of Marketing Communications
10. AmeriHealth Mercy Family of Companies Acquires Community Behavioral HealthCare Network of Pennsylvania
11. Blue Cross and Blue Shield Companies to Host Second Annual National Walk @ Lunch Day(SM) on April 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 1Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 2Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 3Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 4Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 1Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 2Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 1Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 6